Biomedical pressure sensor market seen topping $3.39 billion by 2030

The biomedical pressure sensor market is projected to rise from $2.29 billion in 2026 to $3.39 billion by 2030, driven by remote monitoring, wearables and aging populations. North America held the largest share in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Biomedical pressure sensors are central to monitoring blood pressure, lung pressure and intracranial pressure in real time. - The market’s growth points to broader demand for critical care tools, minimally invasive diagnostics and digital health devices. - The category is becoming more important as healthcare shifts toward personalized medicine and continuous patient monitoring.

What happened: - The Business Research Company released its Biomedical Pressure Sensor Market Report 2026, covering market size, trends and a global forecast through 2035. - The market is projected to grow from $2.07 billion in 2025 to $2.29 billion in 2026. - The report forecasts the market will reach $3.39 billion by 2030. - North America held the largest regional share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - Earlier growth was supported by demand for critical care monitoring, rising cardiovascular disease cases, wider use of invasive pressure monitoring, hospital infrastructure expansion and sensor material improvements. - Future growth is expected to come from remote patient monitoring systems, wearable medical devices, a rising elderly population, minimally invasive diagnostic procedures and closer integration with digital health platforms. - The report highlights continuous physiological pressure monitoring, miniaturized implantable sensors, wireless pressure measurement, high-accuracy MEMS sensors and multi-parameter monitoring devices as emerging trends. - Biomedical pressure sensors measure pressure in biological systems and support diagnosis, ongoing monitoring and medical interventions. - The sensors help detect abnormal pressure changes linked to hypertension, respiratory issues and elevated intracranial pressure. - Personalized medicine is identified as a major driver because real-time pressure data can support tailored therapies and earlier detection of anomalies. - In February 2024, the Personalized Medicine Coalition reported that the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company also offered a free sample report and a full market report.

Between the lines: - The forecast suggests biomedical pressure sensors are moving from a hospital-focused market toward a broader connected-care category. - The combination of wearable devices, wireless measurement and digital health integration signals stronger demand for sensors that fit into home and remote care settings. - The personalized medicine trend adds a second growth engine beyond traditional critical care use.

What's next: - Market growth will likely hinge on adoption of remote monitoring, device miniaturization and digital health integration. - Regional momentum will be shaped by infrastructure investment in North America and rapid healthcare expansion in Asia-Pacific. - Further gains in personalized medicine could push demand for more precise and multi-functional sensing systems.